Amniotic Fluid Stem Cell Features Supporting Their Putative Role in Fetal Cell Microchimerism



Fig. 5.1
Proven features of amniotic fluid stem cells (AFSCs) supporting a role in fetal cell microchimerism



Fetal cell microchimerism is also represented by the presence of fetal DNA in the maternal circulation [2, 3, 21, 38, 47]. Recently, it has been reported that AFSCs underlie a strictly regulated survival control. The capacity of AFSCs to maintain homeostasis via fine-tuned, apoptotic disposal of excess or defective cells was demonstrated by the observation that slight deregulation immediately triggers AFSCs to go into apoptosis [14]. Assuming that AFSCs could be candidates for PAPCs, such a stringent survival control in AFSCs could give rise to cell-free DNA in vivo (Fig. 5.1).

Taking all that into account, AFSCs perfectly fulfil the major features, which must be designated to a stem cell type to be considered as a candidate for the origin of PAPCs. Furthermore, one could also assume AFSCs to be the origin of cell-free, fetal DNA in the mother’s blood, which is already routinely used for non-invasive prenatal diagnosis. Accordingly, we have recently suggested a model in which AFSCs give rise to what we currently know as PAPCs and cell-free, fetal DNA [65].



4 Features, Which Need to be Tested to Further Support a Role of Amniotic Fluid Stem Cells in Fetal Cell Microchimerism


Migration is normally used to describe any directed cell movement within the body, whereas invasion is defined as the penetration of tissue barriers and infiltration into tissues [36]. Extravasation is used to describe the process by which a circulating cell passes through the blood vessel wall into various body areas [39]. Considering everything what is known about PAPCs today, one would assume that these fetal, microchimeric cells harbour additional potentials, such as migration, extravasation and invasion [2, 6, 15, 17, 19, 34, 44, 54] (Fig. 5.2). To our best knowledge, explicit experimental approaches to investigate in detail whether the here described c-kit-positive, monoclonal AFSCs harbour the potential for migration, extravasation or invasion, have not been reported so far.

A306093_1_En_5_Fig2_HTML.gif


Fig. 5.2
Features, which need to be tested to further support a role of AFSCs in fetal cell microchimerism

Last but not least, ultimate support of the hypothesis that AFSCs could function as PAPCs would be to prove that AFSCs floating in the amniotic fluid could finally end as cells in maternal tissues or as cell-free, fetal DNA in the maternal circulation during pregnancy (Fig. 5.2).

Unravelling the identity of PAPCs in support of AFSCs might give answers to two very important questions in stem cell biology: What is the origin of PAPCs? What is the biological function of AFSCs? Accordingly, we think it is absolutely warranted to design experimental settings and approaches to investigate these features in AFSCs.


References



1.

Abdulrazzak H, Moschidou D, Jones G, Guillot PV. Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface. 2010;7:S689–706.PubMedCentralPubMedCrossRef


2.

Bianchi DW. Fetomaternal cell trafficking: a story that begins with prenataldiagnosis and may end with stem cell therapy. J Pediatr Surg. 2007;42:12–8.PubMedCrossRef


3.

Bianchi DW. Prenatal diagnostics: fetal genes in mother’s blood. Nature. 2012;487:304–5.PubMedCrossRef


4.

Bossolasco P, Montemurro T, Cova L, Zangrossi S, Calzarossa C, Miatiotis S, Soligo D, Bosari S, Silani V, Deliliers GL, Rebulla P, Lazzari L. Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res. 2006;16:329–36.PubMedCrossRef


5.

Bou-Gharios G, Amin F, Hill P, Nakamura H, Maxwell P, Fisk NM. Microchimeric fetal cells are recruited to maternal kidney following injury and activate collagen type 1 transcription. Cells Tissues Organs. 2011;193:379–92.PubMedCrossRef


6.

Boyon C, Collinet P, Boulanger L, Rubod C, Lucot JP, Vinatier D. Fetal microchimerism: benevolence or malevolence for the mother? Eur J Obstet Gynecol Reprod Biol. 2011;158:148–52.PubMedCrossRef


7.

DaSacco S, Sedrakyan S, Boldrin F, Giuliani S, Parnigotto PP, Habibian R, Warburton D, DeFilippo RE, Peril L. Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol. 2010;183:1193–200.CrossRef


8.

De Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos TX, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25:100–6.PubMedCrossRef


9.

de Jong A, Dondorp WJ, Frints SG, de Die-Smulders CE, de Wert GM. Advances in prenatal screening: the ethical dimension. Nat Rev Genet. 2011;12:657–63.PubMedCrossRef


10.

Ditadi A, de Coppi P, Picone O, Gautreau L, Smati R, Six E, Bonhomme D, Ezine S, Frydman R, Cavazzano-Calvo M, Andre-Schmutz I. Human and murine amniotic c-Kit + Lin- cells display hematopoietic activity. Blood. 2009;113:3953–60.PubMedCrossRef


11.

Dobreva P, Pereira PNG, Deprest J, Zwijsen A. On the origin of amniotic stem cells: of mice and men. Int J Dev Biol. 2010;54: 761–77.PubMedCrossRef


12.

Dubernard G, Oster M, Chareyre F, Antoine M, Rouzier R, Uzan S, Aractingi S, Khosrotehrani K. Increased fetal cell microchimerism in high grade breast carcinomas occuring during pregnancy. Int J Cancer. 2009;124:1054–9.PubMedCrossRef


13.

Dutta P, Dart ML, Schmacher SM, Burlingham WJ. Fetal microchimerism persists at high levels in c-kit+ stem cells in sensitized mothers. Chimerism. 2010;2:51–5.CrossRef


14.

Fuchs C, Rosner M, Dolznig H, Mikula M, Kramer N, Hengstschläger M. Tuberin and PRAS40 are anti-apoptotic gatekeepers during early human amniotic fluid stem-cell differentiation. Hum Mol Genet. 2012;21:1049–61.PubMedCrossRef


15.

Fugazzola L, Cirello V, Beck-Peccoz P. Fetal microchimerism as an explanation of disease. Nat Rev Endocrinol. 2011;7:89–97.PubMedCrossRef


16.

Fujiki Y, Johnson KL, Peter I, Tighiouart H, Bianchi DW. Fetal cells in the pregnant mouse are diverse and express a variety of progenitor and differentiated cell markers. Biol Reprod. 2009;81:26–32.PubMedCentralPubMedCrossRef


17.

Gammill HS, Nelson JL. Naturally acquired microchimerism. Int J Dev Biol. 2010;54:531–43.PubMedCentralPubMedCrossRef


18.

Gosden CM. Amniotic fluid cell types and culture. Br Med Bull. 1983;39:348–54.PubMed


19.

Groer MW, Manion M, Szekeres C, El-Badri NS. Fetal microchimerism and women’s health: a new paradigm. Biol Res Nurs. 2011;13:346–50.PubMedCrossRef


20.

Guillot PV, O’Donoghue K, Kurata H, Fisk NM. Fetal stem cells: betwixt and between. Semin Reprod Med. 2006;24:340–7.PubMedCrossRef

Mar 22, 2018 | Posted by in BIOCHEMISTRY | Comments Off on Amniotic Fluid Stem Cell Features Supporting Their Putative Role in Fetal Cell Microchimerism
Premium Wordpress Themes by UFO Themes
%d bloggers like this: